title: Chapter V: Diabetic foot.
abstract: Ulcerated diabetic foot is a complex problem. Ischaemia, neuropathy and infection are the three pathological components that lead to diabetic foot complications, and they frequently occur together as an aetiologic triad. Neuropathy and ischaemia are the initiating factors, most often together as neuroischaemia, whereas infection is mostly a consequence. The role of peripheral arterial disease in diabetic foot has long been underestimated as typical ischaemic symptoms are less frequent in diabetics with ischaemia than in non-diabetics. Furthermore, the healing of a neuroischaemic ulcer is hampered by microvascular dysfunction. Therefore, the threshold for revascularising neuroischaemic ulcers should be lower than that for purely ischaemic ulcers. Previous guidelines have largely ignored these specific demands related to ulcerated neuroischaemic diabetic feet. Any diabetic foot ulcer should always be considered to have vascular impairment unless otherwise proven. Early referral, non-invasive vascular testing, imaging and intervention are crucial to improve diabetic foot ulcer healing and to prevent amputation. Timing is essential, as the window of opportunity to heal the ulcer and save the leg is easily missed. This chapter underlines the paucity of data on the best way to diagnose and treat these diabetic patients. Most of the studies dealing with neuroischaemic diabetic feet are not comparable in terms of patient populations, interventions or outcome. Therefore, there is an urgent need for a paradigm shift in diabetic foot care; that is, a new approach and classification of diabetics with vascular impairment in regard to clinical practice and research. A multidisciplinary approach needs to implemented systematically with a vascular surgeon as an integrated member. New strategies must be developed and implemented for diabetic foot patients with vascular impairment, to improve healing, to speed up healing rate and to avoid amputation, irrespective of the intervention technology chosen. Focused studies on the value of predictive tests, new treatment modalities as well as selective and targeted strategies are needed. As specific data on ulcerated neuroischaemic diabetic feet are scarce, recommendations are often of low grade.
authors.affiliation: Department of Vascular Surgery, Helsinki University Central Hospital, Helsinki, Finland. mauri.lepantalo@hus.fi
authors.forename: M
authors.initials: M
authors.lastname: Lepäntalo
authors.forename: J
authors.initials: J
authors.lastname: Apelqvist
authors.forename: C
authors.initials: C
authors.lastname: Setacci
authors.forename: J-B
authors.initials: JB
authors.lastname: Ricco
authors.forename: G
authors.initials: G
authors.lastname: de Donato
authors.forename: F
authors.initials: F
authors.lastname: Becker
authors.forename: H
authors.initials: H
authors.lastname: Robert-Ebadi
authors.forename: P
authors.initials: P
authors.lastname: Cao
authors.forename: H H
authors.initials: HH
authors.lastname: Eckstein
authors.forename: P
authors.initials: P
authors.lastname: De Rango
authors.forename: N
authors.initials: N
authors.lastname: Diehm
authors.forename: J
authors.initials: J
authors.lastname: Schmidli
authors.forename: M
authors.initials: M
authors.lastname: Teraa
authors.forename: F L
authors.initials: FL
authors.lastname: Moll
authors.forename: F
authors.initials: F
authors.lastname: Dick
authors.forename: A H
authors.initials: AH
authors.lastname: Davies
mesh_terms: D000671:Amputation, Surgical; D003646:Debridement; D017719:Diabetic Foot / Q000175:diagnosis* / Q000628:therapy*; D003929:Diabetic Neuropathies / Q000175:diagnosis / Q000628:therapy; D003952:Diagnostic Imaging; D006801:Humans; D007511:Ischemia / Q000175:diagnosis / Q000628:therapy; D016491:Peripheral Vascular Diseases / Q000175:diagnosis / Q000628:therapy; D017410:Practice Guidelines as Topic; D013524:Surgical Flaps; D014656:Vascular Surgical Procedures